Records containing: Stage II Multiple Myeloma

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2013-03-27
CTLA-4 Blockade With MDX-010 to Induce Graft-Versus-Malignancy Effects Following Allogeneic Hematopoietic Stem Cell Transplantation
CLINICAL_TRIALS study record update · 2013-03-06
A Phase II Trial of Sunitinib (SU11248) in Multiple Myeloma
CLINICAL_TRIALS study record update · 2013-02-15
A Phase I/Pilot Study of Intravenous PLERIXAFOR Following Cyclophosphamide Mobilization in Patients With Multiple Myeloma
CLINICAL_TRIALS study record update · 2013-02-07
A Phase I Study of SAHA in Combination With Bortezomib in Relapsed and Refractory Multiple Myeloma
CLINICAL_TRIALS study record update · 2013-01-16
A Phase II Study of Flavopiridol in Patients With Relapsed and Refractory Multiple Myeloma
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2013-01-07
Pharmacokinetic and Phase I Study of Sorafenib (BAY 43-9006, NSC 724772, IND 69896) for Solid Tumors and Hematologic Malignancies in Patients With Hepatic or Renal Dysfunction
CLINICAL_TRIALS study record update · 2012-09-28
Phase II Study of PS-341 for Patients With High-Risk, Newly Diagnosed Multiple Myeloma
CLINICAL_TRIALS study record update · 2012-07-30
Phase II Trial of Intravenously Administered AMD3100 (Plerixafor) for Stem Cell Mobilization in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Following a Lenalidomide Based Initial Therapy
CLINICAL_TRIALS study record update · 2012-03-07
INSPIRE: An Internet-based RCT for Long-term Survivors of Hematopoietic Stem Cell Transplantation